ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) Retained Earnings

Annual Retained Earnings:

-$2.20B+$226.45M(+9.32%)
December 31, 2024

Summary

  • As of today, ACAD annual retained earnings is -$2.20 billion, with the most recent change of +$226.45 million (+9.32%) on December 31, 2024.
  • During the last 3 years, ACAD annual retained earnings has fallen by -$50.81 million (-2.36%).
  • ACAD annual retained earnings is now -3961.64% below its all-time high of -$54.27 million, reached on December 31, 2002.

Performance

ACAD Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

Quarterly Retained Earnings:

-$2.16B+$26.67M(+1.22%)
June 30, 2025

Summary

  • As of today, ACAD quarterly retained earnings is -$2.16 billion, with the most recent change of +$26.67 million (+1.22%) on June 30, 2025.
  • Over the past year, ACAD quarterly retained earnings has increased by +$222.16 million (+9.33%).
  • ACAD quarterly retained earnings is now -3057.62% below its all-time high of -$68.37 million, reached on December 31, 2003.

Performance

ACAD Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ACAD Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+9.3%+9.3%
3Y3 Years-2.4%+6.2%
5Y5 Years-29.4%-17.7%

ACAD Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-2.4%+9.3%at high+12.8%
5Y5-Year-29.4%+9.3%-12.5%+12.8%
All-TimeAll-Time-3961.6%+9.3%-3057.6%+12.8%

ACAD Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$2.16B(+1.2%)
Mar 2025
-
-$2.19B(+0.9%)
Dec 2024
-$2.20B(+9.3%)
-$2.20B(+6.1%)
Sep 2024
-
-$2.35B(+1.4%)
Jun 2024
-
-$2.38B(+1.4%)
Mar 2024
-
-$2.41B(+0.7%)
Dec 2023
-$2.43B(-2.6%)
-$2.43B(+1.8%)
Sep 2023
-
-$2.48B(-2.7%)
Jun 2023
-
-$2.41B(+0.0%)
Mar 2023
-
-$2.41B(-1.8%)
Dec 2022
-$2.37B(-10.0%)
-$2.37B(-1.8%)
Sep 2022
-
-$2.33B(-1.2%)
Jun 2022
-
-$2.30B(-1.5%)
Mar 2022
-
-$2.27B(-5.2%)
Dec 2021
-$2.15B(-8.5%)
-$2.15B(-2.0%)
Sep 2021
-
-$2.11B(-0.7%)
Jun 2021
-
-$2.10B(-2.1%)
Mar 2021
-
-$2.05B(-3.3%)
Dec 2020
-$1.99B(-16.5%)
-$1.99B(-3.5%)
Sep 2020
-
-$1.92B(-4.6%)
Jun 2020
-
-$1.83B(-2.4%)
Mar 2020
-
-$1.79B(-5.2%)
Dec 2019
-$1.70B(-16.0%)
-$1.70B(-3.2%)
Sep 2019
-
-$1.65B(-2.6%)
Jun 2019
-
-$1.61B(-3.5%)
Mar 2019
-
-$1.55B(-5.8%)
Dec 2018
-$1.47B(-20.0%)
-$1.47B(-4.7%)
Sep 2018
-
-$1.40B(-4.6%)
Jun 2018
-
-$1.34B(-5.0%)
Mar 2018
-
-$1.28B(-4.4%)
Dec 2017
-$1.22B(-31.0%)
-$1.22B(-6.0%)
Sep 2017
-
-$1.15B(-6.0%)
Jun 2017
-
-$1.09B(-6.6%)
Mar 2017
-
-$1.02B(-9.4%)
Dec 2016
-$933.98M(-41.0%)
-$933.98M(-9.2%)
Sep 2016
-
-$855.28M(-9.1%)
Jun 2016
-
-$783.67M(-10.0%)
Mar 2016
-
-$712.35M(-7.5%)
Dec 2015
-$662.59M(-33.0%)
-$662.59M(-7.4%)
Sep 2015
-
-$616.80M(-6.7%)
Jun 2015
-
-$577.90M(-7.3%)
Mar 2015
-
-$538.52M(-8.1%)
Dec 2014
-$498.14M
-$498.14M(-6.0%)
Sep 2014
-
-$469.78M(-5.6%)
DateAnnualQuarterly
Jun 2014
-
-$444.99M(-5.1%)
Mar 2014
-
-$423.50M(-4.4%)
Dec 2013
-$405.67M(-10.3%)
-$405.67M(-3.1%)
Sep 2013
-
-$393.62M(-2.8%)
Jun 2013
-
-$382.92M(-2.4%)
Mar 2013
-
-$373.84M(-1.7%)
Dec 2012
-$367.72M(-6.0%)
-$367.72M(-1.9%)
Sep 2012
-
-$360.91M(-0.7%)
Jun 2012
-
-$358.51M(-1.5%)
Mar 2012
-
-$353.09M(-1.8%)
Dec 2011
-$346.87M(-7.0%)
-$346.87M(-1.6%)
Sep 2011
-
-$341.57M(-1.5%)
Jun 2011
-
-$336.50M(-2.0%)
Mar 2011
-
-$329.94M(-1.8%)
Dec 2010
-$324.11M(+4.5%)
-$324.11M(+8.2%)
Sep 2010
-
-$353.25M(-1.2%)
Jun 2010
-
-$349.02M(-1.2%)
Mar 2010
-
-$344.73M(-1.6%)
Dec 2009
-$339.25M(-15.4%)
-$339.25M(-2.6%)
Sep 2009
-
-$330.56M(-2.7%)
Jun 2009
-
-$321.83M(-4.1%)
Mar 2009
-
-$309.10M(-5.1%)
Dec 2008
-$294.10M(-27.9%)
-$294.10M(-5.0%)
Sep 2008
-
-$280.14M(-5.9%)
Jun 2008
-
-$264.52M(-7.4%)
Mar 2008
-
-$246.24M(-7.1%)
Dec 2007
-$229.86M(-32.5%)
-$229.86M(-8.0%)
Sep 2007
-
-$212.82M(-8.2%)
Jun 2007
-
-$196.77M(-5.8%)
Mar 2007
-
-$186.02M(-7.2%)
Dec 2006
-$173.47M(-35.1%)
-$173.47M(-7.7%)
Sep 2006
-
-$161.02M(-7.5%)
Jun 2006
-
-$149.75M(-8.6%)
Mar 2006
-
-$137.88M(-7.4%)
Dec 2005
-$128.42M(-36.2%)
-$128.42M(-8.6%)
Sep 2005
-
-$118.22M(-11.6%)
Jun 2005
-
-$105.91M(-6.0%)
Mar 2005
-
-$99.87M(-5.9%)
Dec 2004
-$94.28M(-26.0%)
-$94.28M(-8.4%)
Sep 2004
-
-$86.95M(-7.7%)
Jun 2004
-
-$80.73M(-7.9%)
Mar 2004
-
-$74.85M(-9.5%)
Dec 2003
-$74.85M(-37.9%)
-$68.37M
Dec 2002
-$54.27M
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual retained earnings year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly retained earnings year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual retained earnings?

The current annual retained earnings of ACAD is -$2.20B

What is the all-time high annual retained earnings for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual retained earnings is -$54.27M

What is ACADIA Pharmaceuticals Inc. annual retained earnings year-on-year change?

Over the past year, ACAD annual retained earnings has changed by +$226.45M (+9.32%)

What is ACADIA Pharmaceuticals Inc. quarterly retained earnings?

The current quarterly retained earnings of ACAD is -$2.16B

What is the all-time high quarterly retained earnings for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly retained earnings is -$68.37M

What is ACADIA Pharmaceuticals Inc. quarterly retained earnings year-on-year change?

Over the past year, ACAD quarterly retained earnings has changed by +$222.16M (+9.33%)
On this page